| Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated SLN Maas, D Stichel, T Hielscher, P Sievers, AS Berghoff, D Schrimpf, ... Journal of clinical oncology 39 (34), 3839-3852, 2021 | 115 | 2021 |
| Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo EP Erkan, D Senfter, S Madlener, G Jungwirth, T Ströbel, N Saydam, ... Cancer gene therapy 24 (1), 38-44, 2017 | 52 | 2017 |
| Identification of KIF11 as a novel target in meningioma G Jungwirth, T Yu, M Moustafa, C Rapp, R Warta, C Jungk, F Sahm, ... Cancers 11 (4), 545, 2019 | 38 | 2019 |
| Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT G Jungwirth, R Warta, C Beynon, F Sahm, A von Deimling, A Unterberg, ... Acta Neuropathologica Communications 7, 1-11, 2019 | 30 | 2019 |
| German Consortium on Aggressive Meningiomas (KAM). Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and … SLN Maas, D Stichel, T Hielscher, P Sievers, AS Berghoff, D Schrimpf, ... J Clin Oncol 39 (34), 3839-3852, 2021 | 26 | 2021 |
| Large-Scale Drug Screening in Patient-Derived IDHmut Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents P Dao Trong, G Jungwirth, T Yu, S Pusch, A Unterberg, C Herold-Mende, ... Cells 9 (6), 1389, 2020 | 23 | 2020 |
| Cytotoxic T cells and their activation status are independent prognostic markers in meningiomas C Rapp, S Dettling, F Liu, AT Ull, R Warta, C Jungk, S Roesch, A Mock, ... Clinical Cancer Research 25 (17), 5260-5270, 2019 | 23 | 2019 |
| KIF11 inhibitors filanesib and ispinesib inhibit meningioma growth in vitro and in vivo G Jungwirth, T Yu, J Cao, MA Eddine, M Moustafa, R Warta, J Debus, ... Cancer Letters 506, 1-10, 2021 | 20 | 2021 |
| Overexpression of minichromosome maintenance protein 10 in medulloblastoma and its clinical implications D Senfter, EP Erkan, E Özer, G Jungwirth, S Madlener, M Kool, T Ströbel, ... Pediatric blood & cancer 64 (12), e26670, 2017 | 13 | 2017 |
| Pharmacological landscape of FDA-approved anticancer drugs reveals sensitivities to ixabepilone, romidepsin, omacetaxine, and carfilzomib in aggressive meningiomas G Jungwirth, T Yu, F Liu, J Cao, M Alaa Eddine, M Moustafa, A Abdollahi, ... Clinical Cancer Research 29 (1), 233-243, 2023 | 9 | 2023 |
| Receptor-tyrosine kinase inhibitor ponatinib inhibits meningioma growth in vitro and in vivo T Yu, J Cao, M Alaa Eddine, M Moustafa, A Mock, C Erkut, A Abdollahi, ... Cancers 13 (23), 5898, 2021 | 7 | 2021 |
| Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion C Blume, H Dogan, L Schweizer, M Peyre, S Doll, D Picard, R Sankowski, ... BioRxiv, 2021.05. 11.443369, 2021 | 6 | 2021 |
| Effective reprogramming of patient-derived M2-polarized glioblastoma-associated microglia/macrophages by treatment with GW2580 V Fermi, R Warta, A Wöllner, C Lotsch, L Jassowicz, C Rapp, M Knoll, ... Clinical Cancer Research 29 (22), 4685-4697, 2023 | 3 | 2023 |
| Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomas H Dogan, C Blume, A Patel, G Jungwirth, L Sogerer, M Ratliff, R Ketter, ... Acta Neuropathologica 144 (4), 799-802, 2022 | 2 | 2022 |
| Preclinical Models of Meningioma G Jungwirth, CO Hanemann, IF Dunn, C Herold-Mende Biological and Clinical Landscape of Meningiomas, 199-211, 2023 | 1 | 2023 |
| DDIS-19. CT-179: An Inhibitor of The Olig2 Transcription Factor with Potent Anti-Tumour Activity In Brain Cancer G Jungwirth, C Jungk, R Warta, A Unterberg Neuro-oncology, 2018 | 1 | 2018 |
| AUTOMATED AND MULTIPLEXED COMBINATORIAL DRUG SCREENING OF FDA-APPROVED DRUGS IDENTIFIES POTENTIAL SYNERGISTIC DRUG PARTNERS FOR THE TREATMENT OF AGGRESSIVE MENINGIOMAS. G Jungwirth, V Braun, R Warta, A Abdollahi, A Unterberg, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells P Dao Trong, G Jungwirth, A Unterberg, C Herold-Mende, R Warta Cells 12 (8), 1200, 2023 | | 2023 |
| MODL-35. A NOVEL PATIENT-DERIVED TUMOR ORGANOID MODEL IDENTIFIES HDACI PANOBINOSTAT AS HIGHLY EFFECTIVE DRUG IN MENINGIOMAS G Jungwirth, J Cao, R Warta, M Moustafa, A Abdollahi, U Andreas, ... Neuro-Oncology 24 (Suppl 7), vii298, 2022 | | 2022 |
| MODL-04. ESTABLISHMENT OF A RELIABLE GLIOBLASTOMA TUMOR-ORGANOID PLATFORM ENABLES AUTOMATED HIGH-THROUGHPUT DRUG SCREENING ADVANCING PERSONALIZED MEDICINE C Herold-Mende, A Paul, J Cao, R Warta, U Andreas, A Abdollahi, ... Neuro-Oncology 24 (Supplement_7), vii291-vii291, 2022 | | 2022 |
